Lin Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Youqian Zhang
Health Science Center, Yangtze University, Jingzhou, China
7 shared publicationsYao Ni
Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, Sichuan Province, China
3 shared publicationsZitian Tang
Health Science Center, Yangtze University, Jingzhou, China
3 shared publicationsYang Wang
Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2 shared publications- Yanrui Ren
Department of Nursing, The First Affiliated Hospital of Yangtze University, Jingzhou, People’s Republic of China
2 shared publications Chunlong Zhang
Health Science Center, Yangtze University, Jingzhou, Hubei, China
1 shared publication
Latest Publications
- 8 June 2024
- Published by Springer Nature in Endocrine
- Vol. 86 (1) , 380-390
The impact of bone mineral density on the risk of falling: evidence from genetic correlation and Mendelian randomization analysis
Background Falls are the most common consequence of low bone mineral density (BMD). However, due to limitations inherent in observational studies, the causal relationship between the two remains unestablished. Methods This study utilized Mendelian Randomization (MR) analysis to explore the causal relationship between BMD and the risk of falling, incorporating linkage disequilibrium score (LDSC) regression for genetic correlation assessment. The primary method was inverse-variance weighted (IVW), supplemented with sensitivity analyses and the causal analysis using summary effect estimates (CAUSE) to address heterogeneity and pleiotropy biases. Results LDSC analysis indicated significant genetic correlations between BMD at various sites and falling risk (rg range: −0.82 to 0.76, all P < 0.05). IVW analysis, with False Discovery Rate (FDR) correction, showed a protective causal effect of total body BMD (OR = 0.85, 95% CI 0.82–0.88, P = 7.63 × 10−17, PFDR = 1.91 × 10−16), femoral neck BMD (OR = 0.81, 95% CI 0.75–0.88, P = 3.33 × 10−7, PFDR = 5.55 × 10−7), lumbar spine BMD (OR = 0.85, 95% CI 0.79–0.91, P = 9.56 × 10−7, PFDR = 1.20 × 10−6), and heel BMD (OR = 0.82, 95% CI 0.79–0.81, P = 1.69 × 10−39, PFDR = 8.45 × 10−39) on falling risk. No causal relationship was found for forearm BMD (OR = 1.02, 95% CI 0.94–1.11, P = 0.64, PFDR = 0.64). Replication datasets and CAUSE analysis provided causal evidence consistent with the main findings. Conclusion The study established a causal relationship between BMD at four different sites and the risk of falling, highlighting potential areas for targeted prevention strategies.
- 8 June 2024
- Published by Springer Nature in Endocrine
- Vol. 86 (1) , 380-390
The impact of bone mineral density on the risk of falling: evidence from genetic correlation and Mendelian randomization analysis
Background Falls are the most common consequence of low bone mineral density (BMD). However, due to limitations inherent in observational studies, the causal relationship between the two remains unestablished. Methods This study utilized Mendelian Randomization (MR) analysis to explore the causal relationship between BMD and the risk of falling, incorporating linkage disequilibrium score (LDSC) regression for genetic correlation assessment. The primary method was inverse-variance weighted (IVW), supplemented with sensitivity analyses and the causal analysis using summary effect estimates (CAUSE) to address heterogeneity and pleiotropy biases. Results LDSC analysis indicated significant genetic correlations between BMD at various sites and falling risk (rg range: −0.82 to 0.76, all P < 0.05). IVW analysis, with False Discovery Rate (FDR) correction, showed a protective causal effect of total body BMD (OR = 0.85, 95% CI 0.82–0.88, P = 7.63 × 10−17, PFDR = 1.91 × 10−16), femoral neck BMD (OR = 0.81, 95% CI 0.75–0.88, P = 3.33 × 10−7, PFDR = 5.55 × 10−7), lumbar spine BMD (OR = 0.85, 95% CI 0.79–0.91, P = 9.56 × 10−7, PFDR = 1.20 × 10−6), and heel BMD (OR = 0.82, 95% CI 0.79–0.81, P = 1.69 × 10−39, PFDR = 8.45 × 10−39) on falling risk. No causal relationship was found for forearm BMD (OR = 1.02, 95% CI 0.94–1.11, P = 0.64, PFDR = 0.64). Replication datasets and CAUSE analysis provided causal evidence consistent with the main findings. Conclusion The study established a causal relationship between BMD at four different sites and the risk of falling, highlighting potential areas for targeted prevention strategies.
- 4 June 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (8) , 587-594
The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis
Previous study has highlighted an association between cannabis use (CU) and an increased risk of erectile dysfunction (ED), potentially due to indirect effects on sex hormonal balance. However, the evidence remains controversial, and the causal relationship is unclear. This study utilized genome-wide association study (GWAS) data to investigate the causal relationships between cannabis use disorder (CUD), lifetime cannabis use (LCU), and ED, as well as levels of sex hormones including estradiol (E2), bioavailable testosterone (BT), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) through Mendelian randomization (MR) analysis. The primary method of analysis was the inverse variance weighted (IVW) method. Data from the FinnGen and UK Biobank were used for replication and meta-analysis. The results indicated no causal relationship between genetically predicted CUD (OR = 0.97, 95% CI 0.87–1.10, P = 0.66) and LCU (OR = 1.13, 95% CI 0.84–1.50, P = 0.42) with the risk of ED. The meta-analysis provided consistent evidence (P > 0.05). No causal relationships were found between CUD and LCU with E2(CUD: β = 0.00, 95% CI 0.00–0.01, P = 0.37; LCU: β = 0.00, 95% CI −0.02–0.01, P = 0.62), BT (CUD: β = 0.00, 95% CI −0.03–0.02, P = 0.90; LCU: β = 0.02, 95% CI −0.04–0.09, P = 0.46), FSH (CUD: β = 0.01, 95% CI −0.18–0.20, P = 0.92; LCU: β = 0.01, 95% CI −0.44–0.47, P = 0.95), and LH (CUD: β = 0.01, 95% CI −0.18–0.21, P = 0.90; LCU: β = 0.13, 95% CI −0.22–0.49, P = 0.46). Sensitivity analyses detected no evidence of horizontal pleiotropy or heterogeneity, ensuring the robustness of the results. In conclusion, this MR analysis did not provide evidence supporting a causal relationship between CU and ED or sex hormone levels.
- 4 June 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (8) , 587-594
The impact of cannabis use on erectile dysfunction and sex hormones: a Mendelian randomization analysis
Previous study has highlighted an association between cannabis use (CU) and an increased risk of erectile dysfunction (ED), potentially due to indirect effects on sex hormonal balance. However, the evidence remains controversial, and the causal relationship is unclear. This study utilized genome-wide association study (GWAS) data to investigate the causal relationships between cannabis use disorder (CUD), lifetime cannabis use (LCU), and ED, as well as levels of sex hormones including estradiol (E2), bioavailable testosterone (BT), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) through Mendelian randomization (MR) analysis. The primary method of analysis was the inverse variance weighted (IVW) method. Data from the FinnGen and UK Biobank were used for replication and meta-analysis. The results indicated no causal relationship between genetically predicted CUD (OR = 0.97, 95% CI 0.87–1.10, P = 0.66) and LCU (OR = 1.13, 95% CI 0.84–1.50, P = 0.42) with the risk of ED. The meta-analysis provided consistent evidence (P > 0.05). No causal relationships were found between CUD and LCU with E2(CUD: β = 0.00, 95% CI 0.00–0.01, P = 0.37; LCU: β = 0.00, 95% CI −0.02–0.01, P = 0.62), BT (CUD: β = 0.00, 95% CI −0.03–0.02, P = 0.90; LCU: β = 0.02, 95% CI −0.04–0.09, P = 0.46), FSH (CUD: β = 0.01, 95% CI −0.18–0.20, P = 0.92; LCU: β = 0.01, 95% CI −0.44–0.47, P = 0.95), and LH (CUD: β = 0.01, 95% CI −0.18–0.21, P = 0.90; LCU: β = 0.13, 95% CI −0.22–0.49, P = 0.46). Sensitivity analyses detected no evidence of horizontal pleiotropy or heterogeneity, ensuring the robustness of the results. In conclusion, this MR analysis did not provide evidence supporting a causal relationship between CU and ED or sex hormone levels.
- 17 May 2024
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (9) , 2075-2084
Multidimensional plasma lipid composition and its causal association with type 2 diabetes mellitus: A Mendelian randomization study
- 17 May 2024
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 34 (9) , 2075-2084
Multidimensional plasma lipid composition and its causal association with type 2 diabetes mellitus: A Mendelian randomization study
- Open Access
- 19 March 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1288886
The protective role of oily fish intake against type 2 diabetes: insights from a genetic correlation and Mendelian randomization study
Background and aims: Previous research has underscored the association between oily fish intake and type 2 diabetes (T2DM), yet the causality remains elusive.Methods: A bidirectional univariable Mendelian Randomization (MR) analysis was employed to evaluate the causal effects of oily fish and non-oily fish intake on T2DM. Replication analysis and meta-analysis were conducted to ensure robust results. Multivariable MR analysis was utilized to assess confounders, and further mediation MR analysis discerned mediating effects. Linkage Disequilibrium Score (LDSC) analysis was undertaken to compute genetic correlations. Inverse variance weighted (IVW) was the primary method, complemented by a series of sensitivity analyses.Results: The LDSC analysis unveiled a significant genetic correlation between oily fish intake and T2DM (Genetic correlation: -0.102, p = 4.43 × 10−4). For each standard deviation (SD) increase in genetically predicted oily fish intake, the risk of T2DM was reduced by 38.6% (OR = 0.614, 95% CI 0.504 ~ 0.748, p = 1.24 × 10−6, False Discovery Rate (FDR) = 3.72 × 10−6). The meta-analysis across three data sources highlighted a persistent causal association (OR = 0.728, 95% CI 0.593 ~ 0.895, p = 0.003). No other causal effects were identified (all p > 0.5, FDR > 0.5). The main outcomes remained consistent in most sensitivity analyses. Both MVMR and mediation MR analyses emphasized the mediating roles of triglycerides (TG), body mass index (BMI), and 25-hydroxyvitamin D (25OHD) levels.Conclusion: To encapsulate, there’s an inverse association between oily fish intake and T2DM risk, suggesting potential benefits of oily fish intake in T2DM prevention.
- 19 March 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1288886
Open AccessThe protective role of oily fish intake against type 2 diabetes: insights from a genetic correlation and Mendelian randomization study
Background and aims: Previous research has underscored the association between oily fish intake and type 2 diabetes (T2DM), yet the causality remains elusive.Methods: A bidirectional univariable Mendelian Randomization (MR) analysis was employed to evaluate the causal effects of oily fish and non-oily fish intake on T2DM. Replication analysis and meta-analysis were conducted to ensure robust results. Multivariable MR analysis was utilized to assess confounders, and further mediation MR analysis discerned mediating effects. Linkage Disequilibrium Score (LDSC) analysis was undertaken to compute genetic correlations. Inverse variance weighted (IVW) was the primary method, complemented by a series of sensitivity analyses.Results: The LDSC analysis unveiled a significant genetic correlation between oily fish intake and T2DM (Genetic correlation: -0.102, p = 4.43 × 10−4). For each standard deviation (SD) increase in genetically predicted oily fish intake, the risk of T2DM was reduced by 38.6% (OR = 0.614, 95% CI 0.504 ~ 0.748, p = 1.24 × 10−6, False Discovery Rate (FDR) = 3.72 × 10−6). The meta-analysis across three data sources highlighted a persistent causal association (OR = 0.728, 95% CI 0.593 ~ 0.895, p = 0.003). No other causal effects were identified (all p > 0.5, FDR > 0.5). The main outcomes remained consistent in most sensitivity analyses. Both MVMR and mediation MR analyses emphasized the mediating roles of triglycerides (TG), body mass index (BMI), and 25-hydroxyvitamin D (25OHD) levels.Conclusion: To encapsulate, there’s an inverse association between oily fish intake and T2DM risk, suggesting potential benefits of oily fish intake in T2DM prevention.
- Open Access
- 7 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0287496
Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis
Background: Previous studies have emphasized the association between the intake of artificial sweeteners (AS) and type 2 diabetes mellitus (T2DM), but the causative relationship remains ambiguous. Methods: This study employed univariate Mendelian randomization (MR) analysis to assess the causal link between AS intake from various sources and T2DM. Linkage disequilibrium score (LDSC) regression was used to evaluate the correlation between phenotypes. Multivariate and mediation MR were applied to investigate confounding factors and mediating effects. Data on AS intake from different sources (N = 64,949) were sourced from the UK Biobank, while T2DM data were derived from the DIAbetes Genetics Replication And Meta-analysis.The primary method adopted was inverse variance weighted (IVW), complemented by three validation techniques. Additionally, a series of sensitivity analyses were performed to evaluate pleiotropy and heterogeneity. Results: LDSC analysis unveiled a significant genetic correlation between AS intake from different sources and T2DM (rg range: -0.006 to 0.15, all P < 0.05). After correction by the false discovery rate (FDR), the primary IVW method indicated that AS intake in coffee was a risk factor for T2DM (OR = 1.265, 95% CI: 1.035–1.545, P = 0.021, PFDR = 0.042). Further multivariable and mediation MR analyses pinpointed high density lipoprotein-cholesterol (HDL-C) as mediating a portion of this causal relationship. In reverse MR analysis, significant evidence suggested a positive correlation between T2DM and AS intake in coffee (β = 0.013, 95% CI: 0.004–0.022, P = 0.004, PFDR = 0.012), cereal (β = 0.007, 95% CI: 0.002–0.012, P = 0.004, PFDR = 0.012), and tea (β = 0.009, 95% CI: 0.001–0.017, P = 0.036, PFDR = 0.049). No other causal associations were identified (P > 0.05, PFDR > 0.05). Conclusion: The MR analysis has established a causal relationship between AS intake in coffee and T2DM. The mediation by HDL-C emphasizes potential metabolic pathways underpinning these relationships
- 7 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0287496
Open AccessAssociations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: A genetic correlation, mediation, and mendelian randomization analysis
Background: Previous studies have emphasized the association between the intake of artificial sweeteners (AS) and type 2 diabetes mellitus (T2DM), but the causative relationship remains ambiguous. Methods: This study employed univariate Mendelian randomization (MR) analysis to assess the causal link between AS intake from various sources and T2DM. Linkage disequilibrium score (LDSC) regression was used to evaluate the correlation between phenotypes. Multivariate and mediation MR were applied to investigate confounding factors and mediating effects. Data on AS intake from different sources (N = 64,949) were sourced from the UK Biobank, while T2DM data were derived from the DIAbetes Genetics Replication And Meta-analysis.The primary method adopted was inverse variance weighted (IVW), complemented by three validation techniques. Additionally, a series of sensitivity analyses were performed to evaluate pleiotropy and heterogeneity. Results: LDSC analysis unveiled a significant genetic correlation between AS intake from different sources and T2DM (rg range: -0.006 to 0.15, all P < 0.05). After correction by the false discovery rate (FDR), the primary IVW method indicated that AS intake in coffee was a risk factor for T2DM (OR = 1.265, 95% CI: 1.035–1.545, P = 0.021, PFDR = 0.042). Further multivariable and mediation MR analyses pinpointed high density lipoprotein-cholesterol (HDL-C) as mediating a portion of this causal relationship. In reverse MR analysis, significant evidence suggested a positive correlation between T2DM and AS intake in coffee (β = 0.013, 95% CI: 0.004–0.022, P = 0.004, PFDR = 0.012), cereal (β = 0.007, 95% CI: 0.002–0.012, P = 0.004, PFDR = 0.012), and tea (β = 0.009, 95% CI: 0.001–0.017, P = 0.036, PFDR = 0.049). No other causal associations were identified (P > 0.05, PFDR > 0.05). Conclusion: The MR analysis has established a causal relationship between AS intake in coffee and T2DM. The mediation by HDL-C emphasizes potential metabolic pathways underpinning these relationships
- 9 December 2023
- Published by Elsevier in Heart & Lung
- Vol. 64, 215-216
The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease
- 9 December 2023
- Published by Elsevier in Heart & Lung
- Vol. 64, 215-216
The gut-lung axis: Mendelian randomization identifies a causal association between inflammatory bowel disease and interstitial lung disease
- 23 November 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 254, 111037
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study
- 23 November 2023
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 254, 111037
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study
- Open Access
- 15 November 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1277984
Serum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study
Background: Previous observational studies have indicated an association between serum uric acid (SUA) and diabetic neuropathy (DN), but confounding factors and reverse causality have left the causality of this relationship uncertain.Methods: Univariate Mendelian randomization (MR), multivariate MR and linkage disequilibrium score (LDSC) regression analysis were utilized to assess the causal link between SUA and DN. Summary-level data for SUA were drawn from the CKDGen consortium, comprising 288,648 individuals, while DN data were obtained from the FinnGen consortium, with 2,843 cases and 271,817 controls. Causal effects were estimated primarily using inverse variance weighted (IVW) analysis, supplemented by four validation methods, with additional sensitivity analyses to evaluate pleiotropy, heterogeneity, and result robustness.Results: The LDSC analysis revealed a significant genetic correlation between SUA and DN (genetic correlation = 0.293, P = 2.60 × 10-5). The primary methodology IVW indicated that each increase of 1 mg/dL in SUA would increase DN risk by 17% (OR = 1.17, 95% CI 1.02-1.34, P = 0.02), while no causal relationship was found in reverse analysis (OR = 1.00, 95% CI 0.98~1.01, P = 0.97). Multivariate MR further identified that the partial effect of SUA on DN may be mediated by physical activity, low density lipoprotein cholesterol (LDL-C), insulin resistance (IR), and alcohol use.Conclusion: The study establishes a causal link between elevated SUA levels and an increased risk of DN, with no evidence for a reverse association. This underscores the need for a comprehensive strategy in DN management, integrating urate-lowering interventions with modulations of the aforementioned mediators.
- 15 November 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1277984
Open AccessSerum uric acid and risk of diabetic neuropathy: a genetic correlation and mendelian randomization study
Background: Previous observational studies have indicated an association between serum uric acid (SUA) and diabetic neuropathy (DN), but confounding factors and reverse causality have left the causality of this relationship uncertain.Methods: Univariate Mendelian randomization (MR), multivariate MR and linkage disequilibrium score (LDSC) regression analysis were utilized to assess the causal link between SUA and DN. Summary-level data for SUA were drawn from the CKDGen consortium, comprising 288,648 individuals, while DN data were obtained from the FinnGen consortium, with 2,843 cases and 271,817 controls. Causal effects were estimated primarily using inverse variance weighted (IVW) analysis, supplemented by four validation methods, with additional sensitivity analyses to evaluate pleiotropy, heterogeneity, and result robustness.Results: The LDSC analysis revealed a significant genetic correlation between SUA and DN (genetic correlation = 0.293, P = 2.60 × 10-5). The primary methodology IVW indicated that each increase of 1 mg/dL in SUA would increase DN risk by 17% (OR = 1.17, 95% CI 1.02-1.34, P = 0.02), while no causal relationship was found in reverse analysis (OR = 1.00, 95% CI 0.98~1.01, P = 0.97). Multivariate MR further identified that the partial effect of SUA on DN may be mediated by physical activity, low density lipoprotein cholesterol (LDL-C), insulin resistance (IR), and alcohol use.Conclusion: The study establishes a causal link between elevated SUA levels and an increased risk of DN, with no evidence for a reverse association. This underscores the need for a comprehensive strategy in DN management, integrating urate-lowering interventions with modulations of the aforementioned mediators.